These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 34557416)
21. Evaluation of Efficacy of Adjuvant Radiotherapy in Well-Differentiated Liposarcoma Patients with Positive Surgical Margins: A Population-based Study. Wang H; Chen B; Cen Y; Chen J J Oncol; 2022; 2022():5735679. PubMed ID: 36117851 [TBL] [Abstract][Full Text] [Related]
22. Comparison between radical surgery and chemoradiotherapy in patients with cervical esophageal cancer: a propensity score matched analysis. Qi K; Lin G; Liu H; Zhang X; Chen Z; Li J BMC Surg; 2023 May; 23(1):119. PubMed ID: 37170089 [TBL] [Abstract][Full Text] [Related]
23. Survival benefits and disparities in radiation therapy for elderly patients with pancreatic ductal adenocarcinoma. Cao BY; Wang QQ; Zhang LT; Wu CC; Tong F; Yang W; Wang J World J Gastrointest Oncol; 2023 Jan; 15(1):155-170. PubMed ID: 36684051 [TBL] [Abstract][Full Text] [Related]
24. Palliative resection or radiation of primary tumor prolonged survival for metastatic esophageal cancer. Xu J; Lu D; Zhang L; Li J; Sun G Cancer Med; 2019 Dec; 8(17):7253-7264. PubMed ID: 31612596 [TBL] [Abstract][Full Text] [Related]
25. Chemoradiotherapy vs radiotherapy for non-surgical locally advanced laryngeal squamous cell carcinoma patients: a propensity score-matched study and practical nomogram construction. Zhang Y; Wang Z; Zheng Y Eur Arch Otorhinolaryngol; 2024 Mar; 281(3):1449-1456. PubMed ID: 38158418 [TBL] [Abstract][Full Text] [Related]
26. Survival benefit of perioperative chemotherapy for T1-3N0M0 stage esophageal cancer: a SEER database analysis. Shao Y; Chen D; Ye L; Wang XM; Wu QC; Zhang C J Thorac Dis; 2021 Feb; 13(2):995-1004. PubMed ID: 33717572 [TBL] [Abstract][Full Text] [Related]
27. Treatment Patterns for Patients With Unresected Stage III NSCLC: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database. Shang S; Wang R; Wang F; Wu M; Chen D; Yu J Front Oncol; 2022; 12():874022. PubMed ID: 35785183 [TBL] [Abstract][Full Text] [Related]
28. Benefit of chemotherapy based on platinum with definitive radiotherapy in older patients with locally advanced esophageal squamous cell carcinoma. Wu H; Yu Y; Zheng Q; Liu T; Wu Y; Wang Z; Zheng H; Liu L; Li J Radiat Oncol; 2021 Oct; 16(1):207. PubMed ID: 34717670 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of Chemotherapy in Survival of Stage I Nasopharyngeal Carcinoma. Ma JL; Huang ST; Jiang YM; Pan XB Front Oncol; 2021; 11():735817. PubMed ID: 34722284 [TBL] [Abstract][Full Text] [Related]
30. The influence of adjuvant radiation therapy after endoscopic resection on survival for early stage EC: an analysis of the surveillance epidemiology and end results (SEER) database. Chen B; Lin J; Ruan Y; Chen Z; Petersen K; Kong M; Shen J; Wang G J Thorac Dis; 2019 Aug; 11(8):3427-3434. PubMed ID: 31559047 [TBL] [Abstract][Full Text] [Related]
31. Radiotherapy benefited the survival of patients with intestinal-type gastric adenocarcinoma: a SEER population-based study. Chu Y; Xu B; Song Q; Hu Q Clin Transl Oncol; 2021 Jan; 23(1):164-171. PubMed ID: 32488805 [TBL] [Abstract][Full Text] [Related]
32. Endoscopic resection Chen H; Hu D; Su W; Li S; Zhang G; Si X; Zhou X Transl Cancer Res; 2024 Feb; 13(2):989-998. PubMed ID: 38482418 [TBL] [Abstract][Full Text] [Related]
33. Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of locally advanced esophageal cancer: a population-based analysis. Qi WX; Chen C; Zhao S; Chen J Int J Clin Oncol; 2022 Feb; 27(2):340-347. PubMed ID: 34731352 [TBL] [Abstract][Full Text] [Related]
34. Adjuvant chemotherapy and survival outcomes in older women with HR+/HER2- breast cancer: a propensity score-matched retrospective cohort study using the SEER database. Ma X; Wu S; Zhang X; Chen N; Yang C; Yang C; Cao M; Du K; Liu Y BMJ Open; 2024 Mar; 14(3):e078782. PubMed ID: 38490656 [TBL] [Abstract][Full Text] [Related]
35. Does the addition of chemotherapy to neoadjuvant radiotherapy impact survival in high-risk extremity/trunk soft-tissue sarcoma? Chowdhary M; Chowdhary A; Sen N; Zaorsky NG; Patel KR; Wang D Cancer; 2019 Nov; 125(21):3801-3809. PubMed ID: 31490546 [TBL] [Abstract][Full Text] [Related]
36. Feasibility and efficacy of chemoradiotherapy for elderly patients with locoregionally advanced nasopharyngeal carcinoma: results from a matched cohort analysis. Liu H; Chen QY; Guo L; Tang LQ; Mo HY; Zhong ZL; Huang PY; Luo DH; Sun R; Guo X; Cao KJ; Hong MH; Mai HQ Radiat Oncol; 2013 Mar; 8():70. PubMed ID: 23521779 [TBL] [Abstract][Full Text] [Related]
37. Real-world analysis of survival benefit of surgery and adjuvant therapy in elderly patients with colorectal cancer. Zhang L; Li Q; Hu C; Zhang Z; She J; Shi F Sci Rep; 2023 Sep; 13(1):14866. PubMed ID: 37684265 [TBL] [Abstract][Full Text] [Related]
38. The survival benefit of adjuvant radiotherapy for pathological T4N2M0 colon cancer in the Modern Chemotherapy Era: evidence from the SEER database 2004-2015. Huang Y; Gu X; Ge K; Fu G; Chu J; Wei W Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):834-840. PubMed ID: 32456465 [TBL] [Abstract][Full Text] [Related]
39. Survival advantage of chemoradiotherapy in anaplastic thyroid carcinoma: Propensity score matched analysis with multiple subgroups. Tian S; Switchenko JM; Fei T; Press RH; Abugideiri M; Saba NF; Owonikoko TK; Chen AY; Beitler JJ; Curran WJ; Gillespie TW; Higgins KA Head Neck; 2020 Apr; 42(4):678-687. PubMed ID: 31845469 [TBL] [Abstract][Full Text] [Related]
40. Adjuvant radiotherapy for patients with pathologic node-negative esophageal carcinoma: A population based propensity matching analysis. Gao HJ; Shang XB; Gong L; Zhang HD; Ren P; Shi GD; Wei YC; Yu ZT Thorac Cancer; 2020 Feb; 11(2):243-252. PubMed ID: 31828980 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]